主要免疫性血小板缺血症的管理:土耳其修改的基于德尔菲的共识声明,以特别考虑
Elif Gülsüm Ümit1, Ahmet Muzaffer Demir1, Muhlis Cem Ar2
1Trakya University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Edirne, Türkiye
概括
土耳其的血液学家达成共识,在怀孕和紧急情况下管理免疫血小板缺血症 (ITP). 制定了分娩和干预期间血小板计数的指导方针,强调对复杂ITP病例的个性化护理.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 初级免疫性血小板缺血 (ITP) 是一种具有复杂,不清楚机制的获得性血小板疾病.
- 目前的ITP管理指南需要针对特定场景,如怀孕,紧急情况和联合药物进行细化.
研究的目的:
- 确定土耳其血液学家在特殊情况下管理免疫血小板缺血 (ITP) 的共识.
- 为怀孕期间,紧急情况和联合治疗期间的ITP管理制定实践指南.
主要方法:
- 土耳其国家ITP工作组使用的修改后的Delphi方法.
- 107名血液学家通过ITP管理声明的问卷进行了两轮调查.
主要成果:
- 关于在有血小板数<30x10^9/L的孕妇患者开始ITP治疗的协议.
- 在血小板计数>50x10 ^ 9 / L时,分娩被认为是安全的;紧急ITP管理更倾向于组合治疗,而不是单独服用高剂量的皮质类固醇.
- 血小板计数>50x10 ^ 9 / L被认为是低风险手术和与抗血小板药物/抗凝剂联合治疗的安全.
结论:
- 需要加强对需要干预和联合治疗的初级ITP患者的实践指导.
- 怀孕期间的ITP管理需要个性化决策.
- 缺乏关于血小板计数值,并发症和并发药物的共识,可能源于实践变化.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K


